This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Anthony Mannino
Introduction
Anthony Mannino is a notable inventor based in Round Lake Beach, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly through his work on terazosin hydrochloride. His innovative approach to chemical processes has led to advancements in medication preparation.
Latest Patents
Mannino holds a patent for a process and intermediate for the preparation of terazosin hydrochloride. This patent details a method for synthesizing 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate. The process involves reacting 4-amino-2-chloro-6,7-dimethoxy-quinazoline with N-(2-tetrahydrofuroyl)piperazine in an anhydrous polar organic solvent without an added acid scavenger. This innovative method produces anhydrous 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride (Form IV), which is then converted to the dihydrate form.
Career Highlights
Mannino is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on pharmaceutical innovations that improve patient outcomes. With a patent portfolio that includes 1 patent, Mannino has established himself as a valuable contributor to the field.
Collaborations
Throughout his career, Mannino has collaborated with esteemed colleagues such as Rodger F. Henry and Wayne R. Heitmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Anthony Mannino's contributions to the field of pharmaceuticals through his innovative patent on terazosin hydrochloride exemplify the impact of dedicated inventors in advancing medical science. His work continues to influence the development of effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
